IBB News and Press, iShares Biotechnology ETF From 10/20/23

2023-10-20 15:19:09 ET You have to neutralize positions when stocks are going bad, said Joe Terranova, chief market strategist for Virtus Investment Partners. He has sold his Invesco QQQ Trust ( NASDAQ: QQQ ) position after the profit and loss was “going the wrong way on ...

2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...

2023-10-18 21:49:00 ET Summary After many years of Cumberland’s US Equity ETF portfolios being overweight in the healthcare sector, we are now at our lowest relative market weight for a long time. The economic benefits to the sector from the Covid pandemic are over. The...

2023-10-12 18:06:30 ET Summary September 2023 saw a surplus of $113B in the US domestic private sector, boosting financial balances. Bank credit creation showed signs of improvement, potentially signaling the start of a speculative credit creation boom. The US sectoral balance...

2023-10-10 07:16:00 ET Summary European countries have been plagued by a persistent medicine shortage for the past few years. Supply chain disruptions and increased demand are driving the shortfall. There are potential solutions; and one could involve breeding a whole lot more...

2023-10-06 18:09:48 ET Summary The biotechnology and pharmaceutical sectors have been under pressure in 2023, with the Invesco Pharmaceuticals ETF down 9% and the iShares Biotechnology ETF down 6%. Elevated interest rates and potential pricing power erosion are the primary headwin...

2023-10-03 12:08:04 ET More on Markets U.S. 10-Year Treasury yield tops 4.75% a level not seen since 2007 BlackRock is overweight AI, calling it a 'mega force' Berenberg: Get defensive with healthcare, utilities and telecoms Citi highlights Info Tech as an Ov...

2023-09-29 23:45:00 ET Summary A combination of public and private investments in neuroscience, government grants, and charitable donations are helping accelerate a wave of advancements and opportunities in neuroscience. Recent clinical trial success for the second significant, di...

2023-09-27 13:50:02 ET More on iShares Biotechnology ETF Biopharma Bounce-Back: From Policy Pains To Profitable Plains IBB: The Illness Of Idiosyncratic Risk BlackRock spotlights healthcare as an opportunity with recession talks in the air Seeking Alphaȁ...

2023-09-22 03:30:00 ET Summary Healthcare stocks often serve as powerful painkillers during market declines. While the MSCI World Index fell by 18.1% in 2022, healthcare stocks fell by only 5.4%. Investing effectively in healthcare stocks requires a unique set of skills. ...